Budgeting for Opioid Addiction Treatment Act

Hozzl · 2023-12-07T17:06:20Z

Explore the details of Senate Bill 2559 Budgeting for Opioid Addiction Treatment Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Taxation. Stay informed on legislative developments.

12/7/2023, 5:06 PM

Summary of Bill S 2559

Bill 118 s 2559, also known as the Budgeting for Opioid Addiction Treatment Act, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to allocate additional funding towards opioid addiction treatment programs in order to address the ongoing opioid crisis in the United States.

The bill proposes to increase funding for various treatment programs, including medication-assisted treatment, counseling services, and support programs for individuals struggling with opioid addiction. Additionally, the bill aims to improve access to these treatment programs for individuals in rural and underserved communities.

One of the key provisions of the Budgeting for Opioid Addiction Treatment Act is the establishment of a grant program that would provide funding to states and local governments to expand and enhance their opioid addiction treatment services. This grant program would prioritize funding for programs that have been proven to be effective in helping individuals overcome opioid addiction. Overall, the Budgeting for Opioid Addiction Treatment Act seeks to address the growing opioid crisis in the United States by providing additional funding for treatment programs and improving access to these programs for individuals in need. This bill is currently being debated in Congress, and its passage could have a significant impact on efforts to combat opioid addiction in the country.

Congressional Summary of S 2559

Budgeting for Opioid Addiction Treatment Act

This bill imposes an excise tax on the sale of any active opioid. The tax is equal to one cent per milligram so sold and it is imposed on the manufacturer, producer, or importer of the opioid. The term active opioid means any controlled substance that is opium, an opiate, or any derivative thereof.

The bill provides block grants for substance abuse treatment programs.

The Department of Health and Human Services must report on the impact of this bill on (1) the retail cost of active opioids; (2) patient access to such opioids, particularly cancer and hospice patients; and (3) the use of tax revenues to improve substance abuse treatment efforts. The report must also make suggestions for improving access to opioids for cancer and hospice patients and substance abuse treatment efforts.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 2559

Bill S 2559 is currently in the status of Bill Introduced since July 27, 2023. Bill S 2559 was introduced during Congress 118 and was introduced to the Senate on July 27, 2023. Bill S 2559's most recent activity was Read twice and referred to the Committee on Finance. as of July 27, 2023

Bipartisan Support of Bill S 2559

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 2559

Primary Policy Focus

Taxation

Alternate Title(s) of Bill S 2559

Budgeting for Opioid Addiction Treatment Act

A bill to amend the Internal Revenue Code of 1986 to establish a stewardship fee on the production and importation of opioid pain relievers, and for other purposes.